Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You ask questions that everybody, including yourself KNOWS the answer to.
Why ask just to be atagonistic.
Question: "Why did they reverse split?"
Answer even a child would understand: To keep from being delisted by Nasdaq.
Simple, straightforward, and OBVIOUS.
WOW, 11:25 and already almost 800 shares traded.
Somebody must know something big.
I don't want to give up on AML until they actually release any definitive bad data.
Well, it's looks like the little train that could ... keeps chug chug chugging along trying it's best to stay above $2.00.
I think it will lose the battle pretty soon.
After that ... the next stop on the line ???
Back to chugging along trying to hold $1.50.
At that point, that train whistle you hear off in the distance on a foggy night ...
might just soung like ... Buy Buy BUYYYY !!!
Hey Phantom, Please ...........................................................
don't let the lunatic fringe bother you.
P.S. GO MRKR Rah Rah Rah
Question? What company already completed a P3 with this technology? Thank You
What will Monday bring and foretell? Will it be strength and accumulation with decent volume as we test the $2.00 lows and try to hold an above $2.00 new bottom?
Or will it be more weakness and selling and testing and breaking below the $2.00 level which brings more selling and increased volume?
The latter being just one more stop among dozens along the ever declining downward track to capitulation.
I am sure I am a crazy because as the saying goes, "what's the definition on insanity?" ... doing the same thing over and over again and expecting a different result", but if this gets down to the $1.50 - $1.60 level ... I guess I'll pull the trigger ... based on nothing but hope for some good trial data news ... at some point ... this year and/or next year ... if management ever decides to clue us investors in again ... at some point and actually does it.
Ah, the Friday DRIP down on a big 5000 share volume so far. The DRIP DRIP DRIP was to be expected after a reverse split, that's OK, just as long as the DRIP doesn't turn into a gravestone that says RIP.
Thanks for your post ... and your insights.
If I remember correctly, the last time management bought was at $1.75, which would be
equivalent to $17.50 post split. Were they just putting up a "good front"? I doubt it.
Did they have something to "believe in"? I don't know, but if they did, it hasn't panned out very well so far. You could say something like ... "you would think they would be buying more at these prices", but they own so much of it already and I sure they will get more on the cheap through options given to them.
Drip, Drip, Drip, are we having fun yet?
Thanks for having my back. The only reason I even saw his post was because I looked at what you were responding to. I have had him blocked for quite a while now. It's just a waste of time to read nonsense. My recent post that I was "damn good" at ... is the exact same thing I said on 12-29, post # 32639 ... and on 10-13, post # 32349 ... and on 5-27, post # 31102.
After watching how stocks react to similar situations for more than 4 decades now, you can kind of take a good guess at what "may" happen in response a given event.
But of course having said that, Boy have I been wrong on MRKR for Many Many Years.
P.S. I was also wrong on PPHM for Many Many Years (now Avid Bioservices ticker CDMO).
Thankfully the list of those I was right on is much much longer and bought several rental condos in Florida and New York which is why I'm just taking MRKR woes in stride and not crying about it (too much ha ha).
Thanks Again (but don't even waste your time on it), on the path to learning, some haven't made it around the curve yet.
After a 60+% pull back fom the RS. Below $1.50, That's what I'm waiting for. Without great news which is not coming anytime soon, it will be a slow trickle down in price.
drip, drip, drip, the bucket has less and less water in it. Went from half full, to quarter full, to 1/10th full, to 1/10th of 1/10th full, and STILL, drip, drip, drip.
Good Luck, I doubt he will answer it .... or anyone.
We will announce trial data results Q1 2022 ..... sorry we meant Q3 2022 ..... oops again we meant EOY 2022 ....... oh Geez just stop listening to us.
Thank God it's Friday ... at least we can look forward to a two day reprieve from the predictable perilous plummeting price plunge.
Now say predictable perilous plummeting price plunge five times fast, click your heels together and maybe we can all wake up and realize this has just been a really bad nightmare.
Then I will definitely buy more.
AGAIN THANK YOU
Phantom, Do you have an idea of if they get all the cash they can from Lincoln Park Vultures, how long will that cash last them past August considering the new trials they want to start? Thanks
Howdy Phantom, Well after my many years posting on this board, you got an idea of how far deep I am in. As I stated a few times, my intention was to wait until after the reverse split, let the share price drop a good bit further as always happens, and then buy more to lower my cost per share.
After reading your posts today ... I don't think I will buy more any time soon.
Wait for good data news release and then buy at a higher price (not the ideal plan) ?
Wait for cash raise dilution and then buy at an even still lower price (throw more $ away) ?
It seems like after missing many announced reporting dates, if they had any good news they would have released it before the reverse split to at least try to avoid it.
QUESTION, if they get all the cash they can from Lincoln Park Vultures, how long will that cash last them past August considering the new trials they want to start?
Now, this is just my opinion but ... THIS SUCKS!
Thank You
Let me guess. They are going to announce that 3 patients went from MRD+ to MRD-, 1 patient had a CR, and they are in talks with Merck in the range of a 3 billion dollar number....................
and then I woke up.
OK, Thanks
OK, Thanks
OK, like a week left. I hope they don't just say "screw it" and let it be delisted. WTF is going on?
12 days left till January 31st. RS when? the suspense is palpable.
That sounds great and I hope so. The only problem for many MRKR investors is that if MRKR goes up 1500% ... that would bring them back to break even.
I started buying many years ago when it was TPIV ... and after the MRKR merge, kept buying more all the way up to $7+ ... and then kept buying more all the way down to 25 cents.
My break even is still pushing $3.
To be honest, as much as I don't like MRKR management as far as their faulty Press Release history. When it comes to what antigens to target, I would tend to trust MRKR scientific team more than some guy with a blog reading other blogs who bought 30 shares of MRKR,
22 days before we have to do a reverse split, just a matter of when. HAPPY NEW YEAR
Howdy, You gave two options:
"They dump it all sometime between now and January to try to bring the share price over $1 as a last push or they wait until after the reverse split and hope the news dump is enough to avoid an immediate decline in share price post reverse split."
OR, the third option, they wait until after the reverse split and hope the BAD news dump is not so BAD that it brings the share price to UNDER a dollar AGAIN.
Hello, Not that I can give any advise after my MANY MANY YEARS of money lost by buying more and more and more of MRKR, but a reverse split is happening vey soon and after the RS that new share price with drop down further, so you might be better off waiting until after the RS to get a better price on a per share basis.
Good Luck and Happy New Year
"Sorry for the rant. My patience is really being tested right now, lol."
Welcome to the club.
Happy New Year
"Lincoln Park may sell or otherwise dispose of the shares of common stock included in this prospectus in a number of different ways and at varying prices."
I guess that is what MRKR meant when they said that Lincoln Park was/is/will be ...
a "long-term Marker shareholder".
I also guess that my definition of "long-term Marker shareholder" must be incorrect.
The B.S. just gets deeper and deeper.
We got the triple negative bad kicking in.
#1 Year end tax loss selling.
#2 Everyone knows a reverse split in happening soon.
#3 We are in bed with vulture Lincoln Park.
But besides that, we are doing great.
HAPPY HOLIDAYS EVERYONE.
He sold me a car the first time I saw his video presentation. It had a cracked engine block and burned a ton of oil, but it sure was pretty and shiny at first sight.
And then like an idiot, I kept buying more and more cars off of him.
You know the old saying:
Fool me once, shame on you. Fool me twice, shame one me.
I wasn't going to mention any of this because I didn't want to bum anybody out.
When the Lincoln Park deal was first announced, I looked at who else they did deals with over the last few years. Except for possibly a couple, they all seem to be dogs, so although the deal MRKR got did seem pretty good for MRKR, the company they now were keeping looked like garbage that just went nowhere quick, and MRKR now being one of those Lincoln Park companies gave me kind of a sick feeling in my stomach.
Old saying ... you are the company that you keep.
https://fintel.io/i/lincoln-park-capital-fund
https://aum13f.com/firm/lincoln-park-capital-fund-llc
https://whalewisdom.com/filer/lincoln-park-capital-fund-llc
As long as your mention "Vulture".
https://utopiacap.com/lincoln-park-capital/
I also looked to see if Lincoln Park was a past or present institutional holder of MRKR and found ZERO, so I guessed that "long-term Marker shareholder" was BS speak for some commitment for the future to be a "long-term Marker shareholder" and not that they WERE a past "long-term Marker shareholder".
So NOW, being in the company of dog companies, and MRKR either using BS speak or just stating plain BS, I am getting that feeling I had when I posted the following in May of 2019.
microcapbiotech
Re: None
Wednesday, May 01, 2019 3:48:03 AM
Post# 26287
OPINIONS PLEASE - I just saw MRKR videos upsetting to me.
WHY is Marker paying a (hype the junk company) like RedChip to do hype videos for them?
Now, everybody here knows I am all for more exposure and even encouraged it on message boards and blogs, but I get an instant bad feeling in my stomach when I see a company paying hype firms and doing hype videos.
90% of the time, companies using hype firms are garbage (that's why they are using hype firms), and it just feels bad to me.
I mean, if you are a reflection of the company you keep (company as in friends, not as in a business company), then why are we hanging out with a hyper like RedChip?
I really LOVE Markers technology and potential, so would someone (or many someones) PLEASE explain to me why I am wrong about this.
That's going to be tough. The AML data coming out soon is for the Active arm patients who are the sickest of the sick, so I don't expect any CR's with them (I hope I'm wrong).
Maybe next year we will get some CR's in the Adjuvant arm patients, but from what I understand, the adjuvant patients will have to be monitored for a much longer time period.
I hope it doesn't happen, but I have kind of resigned myself to a reverse split in the next month.
If it happens, the new higher price will start to drop down (as normal) and then I will just buy more shares.
Lincoln Park Capital Fund has agreed not to cause or engage in any direct or indirect short selling or hedging of Marker's common stock. No warrants are being issued in this transaction, and the Agreement does not contain any rights of first refusal, participation rights, penalties or liquidated damages provisions in favor of any party.
At least that's a positive on top of the positive of the needed cash.
Next comes the negative reverse split.
Not exactly sure what tremtelectogene empogeditemcel or "trem-cel" is. It sounds like from the study that the patient took the CD33-targeted therapy Mylotarg which is made by Pfizer, so I don't know how much of a role that the Vor Biopharma therapy had in the CR.
Whatever "trem-cel" is, is seems to be genitically engineered, so #1 like Car-T which is also genitically engineered, it is probably much more expensive that MRKR Multi-TAA, and #2 being genitically engineered, don't know what side effects will be in larger studies, like cytokine release syndrome.
Not sure if MRKR will have any CR's in the upcoming data as that will be for the Active arm patients who are the sickest of the sick.
Maybe next year we will get some CR's in the Adjuvant arm patients (we hope) (both patients and investors).